Evidence map›Paper›PMID 29190896›Full record

ArticleOncotarget2017

Cofilin 1 promotes bladder cancer and is regulated by TCF7L2.

Fei Wang, Dinglan Wu, Housheng Fu, Fengrong He, Congjie Xu, Jiaquan Zhou, Daoyuan Li, Guoping Li, Jianbing Xu, Qinghui Wu and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Cofilin(s) and Mitochondria: Function Beyond Actin Dynamics.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Nicotine promotes the development of oral leukoplakia via regulating peroxiredoxin 1 and its binding proteins.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Cofilin-2 Acts as a Marker for Predicting Radiotherapy Response and Is a Potential Therapeutic Target in Nasopharyngeal Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Fei Wang *Department of Urology, People's Hospital of Hainan Province, Haikou, China.
Dinglan Wu *The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Housheng FuDepartment of Urology, People's Hospital of Hainan Province, Haikou, China.
Fengrong HeDepartment of Urology, People's Hospital of Hainan Province, Haikou, China.
Congjie XuDepartment of Urology, People's Hospital of Hainan Province, Haikou, China.
Jiaquan ZhouDepartment of Urology, People's Hospital of Hainan Province, Haikou, China.
Daoyuan LiDepartment of Urology, People's Hospital of Hainan Province, Haikou, China.
Guoping LiDepartment of Urology, People's Hospital of Hainan Province, Haikou, China.
Jianbing XuDepartment of Urology, People's Hospital of Hainan Province, Haikou, China.
Qinghui WuDepartment of Urology, People's Hospital of Hainan Province, Haikou, China.
Jianxiang ChenDepartment of Urology, People's Hospital of Hainan Province, Haikou, China.
Liangju SuDepartment of Urology, People's Hospital of Hainan Province, Haikou, China.
Weifu WangDepartment of Urology, People's Hospital of Hainan Province, Haikou, China.
Shufang ZhangCentral Laboratory, Haikou People's Hospital, Central South University Xiangya School of Medicine Affiliated Haikou Hospital, Haikou, China.
Haikou City People's Hospital · CNCentral South University · CNSouthern Medical University Shenzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Earlier reports demonstrated that Cofilin expression is increased in bladder cancer samples, though its function remains unknown. Here, we found that Cofilin 1 expression was higher in bladder cancer tissues than in paracancerous tissues. Overexpression of Cofilin 1 promoted, while Cofilin 1 knockdown inhibited, proliferation, migration, and invasion in the T24 and RT4 bladder cancer cell lines. In addition, Cofilin 1 overexpression increased, while Cofilin 1 knockdown decreased, bladder tumor volumes in mouse xenograft experiments. Transcription factor 7-like 2 (TCF7L2) targeted the promoter of the Cofilin 1 gene, and TCF7L2 knockdown or mutations in the Cofilin 1 promoter dramatically decreased Cofilin 1 transcription. TCF7L2 promoted cell proliferation and migration and increased Cofilin 1 protein levels in RT4 and T24 cells. Thus, TCF7L2 contributed to Cofilin 1-induced promotion of bladder cancer development by binding to the Cofilin 1 promoter and increasing its expression.

Indexed as

bladder cancerCofilin 1depolymerizing factor (ADF)luciferase assaytranscription factor 7-like 2 (TCF7L2)

Identifiers

PMID29190896
PMCPMC5696162
OpenAlexW2753278997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.